Skip to main content

Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide

Conferences
Grupp, SA; Grimley, MS; Driscoll, T; Mahadeo, KM; Leonard, A; Wang, Y; Phillips, H; Justus, D; Lehmann, LE; Esrick, E; Nikiforow, S; Kanter, J ...
Published in: TRANSPLANTATION AND CELLULAR THERAPY
February 2026

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

TRANSPLANTATION AND CELLULAR THERAPY

EISSN

2666-6367

ISSN

2666-6375

Publication Date

February 2026

Volume

32

Issue

2

Start / End Page

S21 / S21

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grupp, S. A., Grimley, M. S., Driscoll, T., Mahadeo, K. M., Leonard, A., Wang, Y., … Manis, J. (2026). Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide. In TRANSPLANTATION AND CELLULAR THERAPY (Vol. 32, pp. S21–S21).
Grupp, Stephan A., Michael S. Grimley, Timothy Driscoll, Kris Michael Mahadeo, Alexis Leonard, Yongping Wang, Helen Phillips, et al. “Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide.” In TRANSPLANTATION AND CELLULAR THERAPY, 32:S21–S21, 2026.
Grupp SA, Grimley MS, Driscoll T, Mahadeo KM, Leonard A, Wang Y, et al. Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide. In: TRANSPLANTATION AND CELLULAR THERAPY. 2026. p. S21–S21.
Grupp, Stephan A., et al. “Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide.” TRANSPLANTATION AND CELLULAR THERAPY, vol. 32, no. 2, 2026, pp. S21–S21.
Grupp SA, Grimley MS, Driscoll T, Mahadeo KM, Leonard A, Wang Y, Phillips H, Justus D, Lehmann LE, Esrick E, Nikiforow S, Kanter J, Hsieh M, Tisdale JF, Sharma A, D Crees Z, Manis J. Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide. TRANSPLANTATION AND CELLULAR THERAPY. 2026. p. S21–S21.

Published In

TRANSPLANTATION AND CELLULAR THERAPY

EISSN

2666-6367

ISSN

2666-6375

Publication Date

February 2026

Volume

32

Issue

2

Start / End Page

S21 / S21

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology